1. Home
  2. GNSS vs GOSS Comparison

GNSS vs GOSS Comparison

Compare GNSS & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genasys Inc.

GNSS

Genasys Inc.

HOLD

Current Price

$1.64

Market Cap

60.1M

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

SELL

Current Price

$10.48

Market Cap

70.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GNSS
GOSS
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.1M
70.8M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
GNSS
GOSS
Price
$1.64
$10.48
Analyst Decision
Strong Buy
Buy
Analyst Count
3
8
Target Price
$3.87
★ $95.40
AVG Volume (30 Days)
76.0K
★ 239.9K
Earning Date
12-08-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 44.44
N/A
EPS
★ N/A
N/A
Revenue
$26,306,790.00
★ $48,471,000.00
Revenue This Year
$39.82
N/A
Revenue Next Year
$12.95
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 29.50
N/A
52 Week Low
$1.17
$0.11
52 Week High
$2.47
$12.52

Technical Indicators

Market Signals
Indicator
GNSS
GOSS
Relative Strength Index (RSI) 68.18 62.53
Support Level $1.58 $0.18
Resistance Level $1.87 $12.49
Average True Range (ATR) 0.08 0.80
MACD 0.04 -0.15
Stochastic Oscillator 89.52 99.58

Price Performance

Historical Comparison
GNSS
GOSS

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Share on Social Networks: